We have detected that
JAVASCRIPT IS NOT ENABLED!
Much of the functionality of mirusbio.com requires Javascript to be enabled.
To avoid issues with site performance, please enable Javascript.
Font
Login
Register
Distributors
Shopping Cart - 0 Items, $0
View
|
Checkout
Research Products
TRANSFECTION
Trans
IT® Product Line
ELECTROPORATION
Ingenio® Product Line
LABELING
Label
IT® Product Line
IN VIVO
DELIVERY
Kits and Vectors
ACCESSORIES
General Accessory Products
Special Programs
Mirus Research Award Program
New Lab Set-up Program
Purchasing Information
Order Direct
Browse Products
International Distributors
Contact Mirus
Special Programs
Mirus Research Award Program
New Lab Set-up Program
Technical Resources
REAGENT AGENT
®
Cell Transfection Database
Citation Database
Product Literature
Protocols
Material Safety Data Sheets (MSDS)
Frequently Asked Questions
Tech Spot
Tips from the Bench
Posters
Papers
Video Library
Contact Mirus
Search
Home
>
Virus Production
Share
Email
Print
Close
Click an icon below to share this page.
Request a Sample
RNA Mediated Virus Production
DNA Mediated Virus Production
Trans
IT for Virus Production
Trans
IT® Transfection Reagents for High-titer Virus Production
Produce virus confidently with validated Mirus products
Trans
IT®-2020,
Trans
IT®-LT1, and
Trans
IT®-293 for recombinant DNA virus production
Trans
IT®-mRNA for recombinant RNA virus production
Increase virus titers with high efficiency, low toxicity transfection reagents
Decrease production time by using lower quantities of nucleic acids and serum compatible reagents
Table 1. Recent Citations for DNA and RNA mediated virus production using
Trans
IT® Transfection Reagents
Virus
Cell Type
Product
Citation
HCV
HuH-7.5
Trans
IT-mRNA
Phan
et al
. J Virol 2011; 85: 1193-1204.
CCHFV
BSR-T7/5
Trans
IT-mRNA
Bergeron
et al
. J Virol 2010; 84: 216-226.
HIV-1
293T
Trans
IT-LT1
Galli
et al
. J Virol 2010; 84: 7651-7661.
Influenza H5N1
293T
Trans
IT-LT1
Imai
et al
. PLoS Path 2010; 6: e1001106.
HCV
HuH-7
Trans
IT-mRNA
Jangra et al. J Virol 2010; 84: 6615-6625.
Lentivirus
293T
Trans
IT-293
Kato
et al.
J Biochem 2010; 147: 63-71.
VLP
293T
Trans
IT-293
Crist
et al
. J Virol 2009; 83: 2216-2225.
HTLV-1
293T
Trans
IT-LT1
Lamb
et al
. JBC 2009; 284: 6575-6584.
SIV/SK
293T/MDCK
Trans
IT-LT1
Masic
et al
. J Gen Virol 2009; 90: 375-385.
Retrovirus
Phoenix Eco
TransTI-LT1
Saxena
et al
. Mol Cell Bio 2009; 29: 2335-2345.
Influenza H9N2
293T/MDCK
Trans
IT-LT1
Xing
et al
. J Gen Virol 2009; 90: 1109-1118.
HEV
PLC/PFR/5
Trans
IT-mRNA
Yamada
et al
. J Gen Virol 2009; 90: 457-462.
Influenza H5N1
293T
Trans
IT-LT1
Yen
et al
. PNAS 2009; 106: 286-291.
Table 2. Comparison of
Trans
IT® Transfection Reagents
Trans
IT-2020
Trans
IT-LT1
Trans
IT-293
Trans
IT-mRNA
Transfect DNA or RNA
DNA
DNA
DNA
RNA
High Efficiency
Low Cell Toxicity
Serum Compatible
Easy-to-Use
Broad Spectrum Delivery
-
Animal Origin Free
-
-
Citations
New
Figure 1.
Trans
IT Transfection Reagents are Serum Compatible.
All
Trans
IT Transfection Reagents are low toxicity and do not require a media change. Save time and money by adding formed complexes directly to cells in media containing serum and avoiding unnecessary media changes.
Prove It to Yourself!
Products
Transfection
Electroporation
Labeling
In Vivo
Delivery
Accessories
Special Programs
Research Award Program
New Lab Set-up Program
Technical Resources
NEW! Reagent Agent
®
Citations
Protocols
MSDS
Frequently Asked Questions
Tips from the Bench
Posters
Papers
Video Library
Company Overview
Corporate Profile
Employment
Directions
Events
News
Technologies
Contact Information
Contact Mirus
International Distributors
Purchasing
Ordering Information
Order Direct
Browse Products
View Cart
Tools
Site Search
Print this Page
Email this Page
Share This Page
Mirus Bio Homepage
Sitemap
© 2012 Mirus Bio LLC. All Rights Reserved. Legal ::
Terms and Conditions
|
Privacy Policy
|
Patents and Trademarks
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Processing...